Topical creams are becoming part of the mix of pain treatment options as doctors look for alternatives to addictive opioids.
Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) fell for the first time in the U.S.—dropping to 2.92% last quarter, a decrease of 7%. This decline coincided with a 6.3% reduction in new BEV purchases compared to Q2 2024 despite record-breaking sales earlier in the year. Consumer demand is being tested as federal tax incentives are set to expire in September while discounts for electrified options reached an all-time high of nearly $8,500 per automobile by the end of the quarter.
When entrusting a vendor with your medical records summarization needs, speed will get you a quick summary but integrating clinical insight with AI processes is a necessity to support well-informed claims decisions. The right vendor understands how AI cannot replace human insight and leverages both to help protect your organization from costly errors.
Enlyte SVP Kim Radcliffe shares why direct physical therapy access should be a frontline strategy in workers’ comp. Learn how it reduces delays, lowers costs, and improves return-to-work outcomes.
Adjusters are often considered the foundation of insurance industry success, but their vital role is often underappreciated. So, once again, Enlyte is celebrating these professionals in honor of National Adjuster Day, Aug. 17, by launching another product designed to make their lives easier.
Physical therapy (PT) plays a central role in recovery. But without clear targets, treatment can easily extend longer than necessary, delaying return to work and increasing costs. That’s where clinical guidelines come in. They provide benchmarks for treatment progression, expected visit counts, and documentation standards—all critical elements needed to ensure appropriate care, reduce friction, and keep claims moving forward.
Why are U.S. prescription drug prices so much higher than in other developed nations—and what is the government doing about it? A new executive order from the White House could shake up how brand-name drugs are priced and reimbursed, with potential ripple effects across auto and workers’ comp. But is it really a game-changer, or just another attempt at reducing drug costs? Brian Allen, VP of Government Affairs breaks down the executive order and what it could mean for work comp and auto.